These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 39259115)
1. Short-term (1-3 months) versus standard (12 months) dual antiplatelet therapy following new-generation drug-eluting stent implantation: A meta-analysis of randomized controlled trials. Xiong P; Zheng C; Fan J; Zhang H; Li C Medicine (Baltimore); 2024 May; 103(22):e38071. PubMed ID: 39259115 [TBL] [Abstract][Full Text] [Related]
2. Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trial. Ge Z; Gao XF; Kan J; Kong XQ; Zuo GF; Ye F; Tian NL; Lin S; Liu ZZ; Shao YB; He YQ; Wen SY; Yang Q; Xia Y; Wang ZZ; Xiao PX; Li F; Zeng HS; Yang S; Wang Y; Tao L; Gao DS; Qu H; Qian XS; Han YL; Chen F; Zhang JJ; Chen SL Am Heart J; 2021 Jun; 236():49-58. PubMed ID: 33621541 [TBL] [Abstract][Full Text] [Related]
3. Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis. Yin SH; Xu P; Wang B; Lu Y; Wu QY; Zhou ML; Wu JR; Cai JJ; Sun X; Yuan H BMJ; 2019 Jun; 365():l2222. PubMed ID: 31253632 [TBL] [Abstract][Full Text] [Related]
4. Short-term vs long-term dual antiplatelet therapy after drug-eluting stent implantation in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis. Li J; He K; Ge J; Li C; Jing Z Int J Clin Pract; 2021 Jul; 75(7):e13938. PubMed ID: 33341109 [TBL] [Abstract][Full Text] [Related]
5. One-Month Dual Antiplatelet Therapy Reduces Major Bleeding Compared With Longer-Term Treatment Without Excess Stent Thrombosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Bajraktari G; Bytyçi I; Abdyli G; Ibrahimi P; Bajraktari A; Karahoda R; Elezi S; Henein MY Am J Cardiol; 2024 Sep; 227():91-97. PubMed ID: 39029722 [TBL] [Abstract][Full Text] [Related]
6. The optimal discontinuation of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention with drug-eluting stents: A meta-analysis of randomized trials. Wang W; Liu J; Fang J; Liu Y; An T; Zou M; Cheng G Int J Cardiol; 2017 May; 235():73-86. PubMed ID: 28284499 [TBL] [Abstract][Full Text] [Related]
7. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Bittl JA; Baber U; Bradley SM; Wijeysundera DN J Am Coll Cardiol; 2016 Sep; 68(10):1116-39. PubMed ID: 27036919 [TBL] [Abstract][Full Text] [Related]
8. Benefits of short-term or prolonged as compared to standard 1 year DAPT in patients with acute coronary syndrome treated with drug-eluting stents: a meta-analysis of 9 randomized trials. Verdoia M; Kedhi E; Suryapranata H; Frati G; Biondi-Zoccai G; De Luca G J Thromb Thrombolysis; 2020 Aug; 50(2):337-354. PubMed ID: 31919736 [TBL] [Abstract][Full Text] [Related]
9. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. ; Bittl JA; Baber U; Bradley SM; Wijeysundera DN Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019 [TBL] [Abstract][Full Text] [Related]
10. Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials. Giacoppo D; Matsuda Y; Fovino LN; D'Amico G; Gargiulo G; Byrne RA; Capodanno D; Valgimigli M; Mehran R; Tarantini G Eur Heart J; 2021 Jan; 42(4):308-319. PubMed ID: 33284979 [TBL] [Abstract][Full Text] [Related]
11. Optimal Duration of Dual Antiplatelet Therapy after Drug-Eluting Stents: Meta-Analysis of Randomized Trials. Abo-Salem E; Alsidawi S; Jamali H; Effat M; Helmy T Cardiovasc Ther; 2015 Oct; 33(5):253-63. PubMed ID: 26010419 [TBL] [Abstract][Full Text] [Related]
12. Short- versus standard-term dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation: A meta-analysis. Basaraba JE; Barry AR J Cardiol; 2017 Jan; 69(1):353-358. PubMed ID: 27590413 [TBL] [Abstract][Full Text] [Related]
13. Duration of dual antiplatelet therapy following drug-eluting stent implantation: A systemic review and meta-analysis of randomized controlled trials with longer follow up. Sharma A; Agrawal S; Garg A; Vallakati A; Lavie CJ; Helft G Catheter Cardiovasc Interv; 2017 Jul; 90(1):31-37. PubMed ID: 28557264 [TBL] [Abstract][Full Text] [Related]
14. Short-Term Versus Long-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Elderly Patients: A Meta-Analysis of Individual Participant Data From 6 Randomized Trials. Lee SY; Hong MK; Palmerini T; Kim HS; Valgimigli M; Feres F; Colombo A; Gilard M; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Stone GW JACC Cardiovasc Interv; 2018 Mar; 11(5):435-443. PubMed ID: 29454730 [TBL] [Abstract][Full Text] [Related]
15. Comparison of biodegradable and newer generation durable polymer drug-eluting stents with short-term dual antiplatelet therapy: a systematic review and Bayesian network meta-analysis of randomized trials comprising of 43,875 patients. Chong B; Goh RSJ; Kong G; Sim FRE; Ng CH; Teo XYV; Quek JX; Lim O; Chin YH; Chan SP; Chan MY; Tan HC; Chew NWS; Loh PH J Thromb Thrombolysis; 2022 Apr; 53(3):671-682. PubMed ID: 34981305 [TBL] [Abstract][Full Text] [Related]
16. Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials. Giustino G; Baber U; Sartori S; Mehran R; Mastoris I; Kini AS; Sharma SK; Pocock SJ; Dangas GD J Am Coll Cardiol; 2015 Apr; 65(13):1298-1310. PubMed ID: 25681754 [TBL] [Abstract][Full Text] [Related]
17. Determinants and Clinical Outcomes of Extended Dual Antiplatelet Therapy over 3 Years after Drug-Eluting Stent Implantation: A Retrospective Analysis. Lee OH; Kim BK; Hong SJ; Kim S; Ahn CM; Shin DH; Kim JS; Kang TS; Ko YG; Choi D; Hong MK; Jang Y Yonsei Med J; 2020 Jul; 61(7):597-605. PubMed ID: 32608203 [TBL] [Abstract][Full Text] [Related]
18. Dual antiplatelet therapy after percutaneous coronary intervention in patients at high bleeding risk: A systematic review and meta-analysis. Han Y; Yuan X; Hu X; Fang Y; Jiang M; Feng H; Gao L Cardiol J; 2023; 30(4):556-566. PubMed ID: 35912712 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of Short-term Dual Antiplatelet Therapy after Implantation of Second-generation Drug-eluting Stents: A Meta-analysis and Systematic Review. Huang P; Yu Y; Han X; Yang Y Chin Med Sci J; 2017 Apr; 32(1):1-12. PubMed ID: 28399979 [TBL] [Abstract][Full Text] [Related]
20. Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial. Colombo A; Chieffo A; Frasheri A; Garbo R; Masotti-Centol M; Salvatella N; Oteo Dominguez JF; Steffanon L; Tarantini G; Presbitero P; Menozzi A; Pucci E; Mauri J; Cesana BM; Giustino G; Sardella G J Am Coll Cardiol; 2014 Nov 18-25; 64(20):2086-97. PubMed ID: 25236346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]